Core Laboratories (Core Laboratories) Debt-to-Asset

: 0.40 (As of Mar. 2023)

View and export this data going back to 1995. Start your Free Trial

Core Laboratories's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2023 was $11.1 Mil. Core Laboratories's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2023 was $224.2 Mil. Core Laboratories's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Mar. 2023 was $593.6 Mil. Core Laboratories's debt to asset for the quarter that ended in Mar. 2023 was 0.40.

Core Laboratories Debt-to-Asset Historical Data

The historical data trend for Core Laboratories's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Core Laboratories Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Debt-to-Asset

0.45

0.49

0.58

0.43

0.39

Core Laboratories Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Debt-to-Asset																0.43	0.42	0.41	0.39	0.40

Competitive Comparison

For the Oil & Gas Equipment & Services subindustry, Core Laboratories's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Core Laboratories Debt-to-Asset Distribution

For the Oil & Gas industry and Energy sector, Core Laboratories's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Core Laboratories's Debt-to-Asset falls into.

Core Laboratories Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Core Laboratories's Debt-to-Asset for the fiscal year that ended in Dec. 2022 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(11.699	+	210.691)	/	578.354
	=	0.38

Core Laboratories's Debt-to-Asset for the quarter that ended in Mar. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(11.073	+	224.233)	/	593.617
	=	0.40

Core Laboratories (NYSE:CLB) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Core Laboratories Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Core Laboratories's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Core Laboratories (Core Laboratories) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Energy » Oil & Gas » Core Laboratories Inc (NYSE:CLB) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

6316 Windfern Road, Houston, TX, USA, 77040

Website

https://www.corelab.com

Core Laboratories is the premier provider of reservoir description and production enhancement services for oil and gas exploration and production. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services.

Executives

Katherine Murray	director	6316 WINDFERN ROAD, HOUSTON TX 77040
Mark Damian Tattoli	officer: SVP, Gen Counsel & Secretary	C/O CORE LABORATORIES LP, 6316 WINDFERN ROAD, HOUSTON TX 77040
Kwaku Temeng	director	C/O CORE LABORATORIES LP, 2216 SHERIDAN STREET, HOUSTON TX 77002
Gwendolyn Schreffler	officer: SVP	C/O CORE LABORATORIES LP, 6316 WINDFERN ROAD, HOUSTON TX 77040
Harvey Robert Klingensmith	director	P.O. BOX 131144, HOUSTON TX 77219-1114
Van Dijken Eeuwijk Monique	director	P.O. BOX 129, BILTHOVEN P7 3720 AC
Jan Willem Sodderland	director	DUINDISTEL 89, NOORDWIJK P7 2202 DE
Goldman Sachs Group Inc	10 percent owner	200 WEST STREET, NEW YORK NY 10282
Goldman Sachs & Co. Llc	10 percent owner	200 WEST STREET, NEW YORK NY 10282
Lawrence Bruno	officer: President	6316 WINDFERN ROAD, HOUSTON TX 77040
Mark F Elvig	officer: VP, Counsel & Secretary	6316 WINDFERN, HOUSTON TX 77040
Gregory Barry Barnett	director	853 MILWAUKEE STREET, DENVER CO 80206
Kevin Daniels	officer: CAO & Treasurer	6316 WINDFERN ROAD, HOUSTON TX 77040
Michael Straughen	director	68 RUBISLAW DEN NORTH, ABERDEEN X0 AB15 4AN
Martha Z. Carnes	director	6316 WINDFERN ROAD, HOUSTON TX 77040